Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease

YILMAZ Y., Ozturk O., Alandab Y., Senates E., ÇOLAK Y., Doganay H. L., ...Daha Fazla

DIGESTIVE AND LIVER DISEASE, cilt.45, sa.1, ss.58-62, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1016/j.dld.2012.08.017
  • Dergi Adı: DIGESTIVE AND LIVER DISEASE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.58-62
  • Anahtar Kelimeler: Biomarker, Inflammation, Nonalcoholic fatty liver disease, Osteopontin, Portal inflammation, METABOLIC SYNDROME, HEPATOCELLULAR-CARCINOMA, STEATOHEPATITIS, ASSOCIATION, STEATOSIS, OBESITY, MARKER, EXPRESSION, FIBROSIS, HEDGEHOG
  • Marmara Üniversitesi Adresli: Evet

Özet

Background: Osteopontin is a secreted phosphorylated glycoprotein that is expressed by a variety of cell types and that mediates numerous and diverse biological functions.